Immune Tolerance to Drugs. I. Long‐Term Tolerability of Rokitamycin in Patients with Antibiotics Hypersensitivity

References

• Lode H., Stahlmann R. Evaluation of safety and tolerance in clinical trials with antimicrobials agent. Eur. J. Clin. Microbiol. Infect. Dis. 1990; 9: 530–533
   PubMedGoogle Scholar
• Shepherd G. M. Allergy to β lactams antibiotics. Immunol. Allergy Clin. North Am. 1991; 11: 611
   Web of Science ®Google Scholar
• Asero R. Detection of patients with multiple drug allergy syndrome by elective tolerance test. Ann. Allergy Asthma Immunol. 1998; 80: 185–189
   PubMed Web of Science ®Google Scholar
• Nettis E., Colanardi M. C., Di Paola R., Ferrannini A., Tursi A. Tolerance test in patients with multiple drug allergy syndrome. Immunopharmacol. Immunotoxicol. 2001; 23: 617–626
   PubMed Web of Science ®Google Scholar
• Naldi L., Conforti A., Venegoni M., Troncon M. G., Caputi A., Ghiotto E., Cocci A., Moretti U., Velo G., Leone R. Cutaneneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br. J. Clin. Pharmacol. 1999; 48: 839–846
   PubMed Web of Science ®Google Scholar
• Van der Linden P. D., van der Lei J., Vlug A. E., Stricker B. H. Skin reactions to antibacterial agents in general practice. J. Clin. Epidemiol. 1998; 51: 703–708
   PubMed Web of Science ®Google Scholar
• Periti P., Mazzei T., Mini E., Novelli A. Adverse effects of macrolide antibacterials. Drug Saf. 1993; 9: 346–364
   PubMed Web of Science ®Google Scholar
• Walsh J. H., Peterson W. L. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N. Engl. J. Med. 1995; 333: 984–991
   PubMed Web of Science ®Google Scholar
• Peterson J. G., McColl K. E.L. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br. J. Clin. Pharmacol. 1997; 43: 223–243
   PubMedGoogle Scholar
• Jaffe A., Bush A. Anti‐inflammatory effects of macrolides in lung disease. Pediatr. Pulmonol. 2001; 31: 464–273
   PubMed Web of Science ®Google Scholar
• Spahn J. D., Fost D. A., Covar R., Martin R. J., Brown E. E., Szefler S. J., Leung D. Y. Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study. Ann. Allergy Asthma Immunol. 2001; 87: 501–505
   PubMed Web of Science ®Google Scholar
• Yu K. W., Briones F., Chin N. X., Neu H. C. Antibacterial activity of rokitamycin compared with that of other macrolides. Diagn. Microbiol. Infect. Dis. 1991; 14: 331–335
   PubMedGoogle Scholar
• Bryskier A., Labro M. T. Macrolides. New therapeutic prospects. Presse Med. 1994; 23: 1762–1766
   PubMed Web of Science ®Google Scholar
• Morohoshi T., Tanini T., Nishino T. Bacteriological evaluation of a new macrolide antibiotic TMS‐19‐19‐Q (3‐O‐propionyl‐leucomycin A5). Chemotherapy 1984; 32: 12–25
   Google Scholar
• Cinco M., Padovan D., Stinco G., Trevisan G. In vitro activity of rokitamycin, a new macrolide, against Borrelia burgdoferi. Antimicrob. Agents Chemoter. 1995; 39: 1185–1186
   PubMedGoogle Scholar
• Morishita M., Suzuki T., Sakai A., Endo S., Watanabe M., Nagata A., Ishioka T. Studies on absorption, metabolism and excretion of TMS‐19‐Q in humans. J. Chemother. 1984; 32: 99–115
   Google Scholar
• Goto S., Tsuji A., Ogawa M., Yokoyama S., Sagai H., Toriya M., Morohoshi T., Hayano K. Bacteriological evaluations of the metabolites of TMS‐19‐Q, a new macrolide antibiotic. J. Chemother. 1984; 32: 37–45
   Google Scholar
• Cazzola M., Matera M. G., Paterno E., Scaglione F., Santangelo G., Rossi F. Impact of rokitamycin, a new 16‐membered macrolide, on serum theophylline. J. Chemother. 1991; 3: 240–244
   PubMed Web of Science ®Google Scholar
• Morishita M., Suzuki T., Hayano K. The in vivo pharmacokinetics of rokitamycin: a new macrolide antibiotic. Chemother. Field 1987; 3: 381–390
   Google Scholar
• Morishita M., Ohno M., Serizawa K., Fujiwara T., Sakakibara H. Isolation and identification of metabolites of TMS‐19‐Q. J. Chemother. 1984; 32: 85–92
   Google Scholar
• Slater J. E. Hypersensitivity to macrolide antibiotics. Ann. Allergy 1991; 66: 193–195
   PubMedGoogle Scholar
• Demoly P., Benahmed S., Valembois H., Sahla H., Messaad D., Goodard P. H., Michel F. B., Bousquet J. L'allergie aux macrolides. Revue de la littérature. Press. Med. 2000; 29: 321–326
   PubMedGoogle Scholar
• Kawauchi K., Sato Y., Kimura S., Yonesaka S., Yokoyama M., Onishi A., Asuka T., Okamoto T., Takebe Y., Tsushima T. Clinical results of a rokitamycin dry syrup in pediatric infections. J.P.N. J. Antibiot. 1998; 41: 673–685
   Google Scholar
• Gallardo M. A., Thomas I. Hypersensitivity reaction to erythromycin. Cutis 1999; 64: 374–376
   Google Scholar
• Kruppa A., Scharffetter‐Kochanek K., Krieg T., Hunzelmann N. Immediate reaction to roxithromycin and prick test cross‐sensitization to rythromycin and clarithromycin. Dermatology 1998; 196: 335–336
   PubMedGoogle Scholar
• Tonnesen M. G., Harrist T. J., Wintroub B. V., Mihm M. C., Jr., Soter N. A. Erythema multiforme: microvascular damage and infiltration of lymphocytes and basophils. J. Invest. Dermatol. 1983; 80: 282–286
   PubMed Web of Science ®Google Scholar
• Correia O., Delgado L., Ramos J. P., Resende C., Torrinha J. A. Cutaneous T‐cell recruitment in toxic epidermal necrolysis: further evidence of CD8+ lymphocyte involvement. Arch. Dermatol. 1993; 129: 466–468
   PubMedGoogle Scholar
• Smith J. W., Johnson J. E., Cuff L. E. Studies on the epidemiology of adverse drug reactions. An evaluation of penicillin allergy. N. Eng. J. Med. 1966; 274: 998–1002
   PubMed Web of Science ®Google Scholar
• Riario‐Sforza G., Zara C., Incorvaia C. Atopy as a risk factor in drug allergy: a prospective study [abstract]. Allergy 1996; 51: 74
   Google Scholar
• Pastorello E. A., Zara C., Riario‐Sforza G., Pravettoni V., Incorvaia C. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti‐inflammatory. Allergy 1998; 53: 880–884
   PubMedGoogle Scholar
• Quiralte J., Blanco C., Castillo R., Delgado J., Carrillo T. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J. Allergy Clin. Immunol. 1996; 98: 678–685
   PubMed Web of Science ®Google Scholar
• Sullivan T. J., Ong R. C., Gilliam L. K. Studies of the multiple drug allergy syndrome. [abstract]. J. Allergy Clin. Immunol. 1989; 83: 270
   Google Scholar